Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc. (BOW) Market Cap

Bowhead Specialty Holdings Inc. has a market capitalization of $841.6M.

Price: $25.63

-0.12 (-0.47%)

Market Cap: 841.64M

NYSE · time unavailable

CEO: Stephen Jay Sills

Sector: Financial Services

Industry: Insurance - Property & Casualty

IPO Date: 2008-08-28

Website: https://bowheadspecialty.com

Bowhead Specialty Holdings Inc. (BOW) - Company Information

Market Cap: 841.64M|Sector: Financial Services

Company Profile

Bowhead Specialty Holdings Inc. provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments. The company distributes its products through distribution partners in wholesale and retail markets. Bowhead Specialty Holdings Inc. was formerly known as Bowhead Holdings Inc. and changed its name to Bowhead Specialty Holdings Inc. in March 2024. The company was founded in 2020 and is based in New York, New York. Bowhead Specialty Holdings Inc. operates as a subsidiary of Bowhead Insurance Holdings LP.

Analyst Sentiment

74%
Strong Buy

From 7 Active Polls

1Y Forecast: $29.00

▲ +13.1% Potential Upside

Consensus Target Metrics

Low Bound

$27

Median

$28

High Bound

$32

Average

$29

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$29.00
▲ +13.15% Upside
Low Target
$27.00
5% Risk
Median Target
$28.00
9% Mid
High Target
$32.00
25% Max
Consensus
Buy
5 / 7 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)8427369368861,2281,3281,160915694
Enterprise Value ($M)7005947026361,0621,2401,067753514
Price to Earnings Ratio (P/E)14.4111.4915.7614.6024.8829.0521.3218.9131.36
Price/Earnings-to-Growth Ratio (PEG)5.582.911.812.9310.109.551.053.44
Price to Sales Ratio (P/S)1.444.756.176.169.2210.829.727.847.02
Price to Book Ratio (P/B)1.841.612.092.063.023.393.132.512.04
Price to Free Cash Flow Ratio (P/FCF)2.4611.4716.477.8111.4328.5619.057.729.81
Enterprise Value to Sales (EV/Sales)3.844.634.427.9710.108.946.455.19
Enterprise Value to EBITDA (EV/EBITDA)9.1528.8935.7932.0664.2282.0054.4543.9859.77
Debt to Equity Ratio-1.850.01

BOW Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$25.63
Intrinsic Value$25.61
Market Alignment
Overvalued by 0.1%relative to calculated intrinsic value
9.00%
Exp: 12%12%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.10B
Perpetuity TV Value$1.83B
Discounted TV (PV)$0.77B
TV Weighting %65.3%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 BOWHEAD SPECIALTY HOLDINGS INC (BOW) — Investment Overview

🧩 Business Model Overview

Bowhead Specialty Holdings operates as a specialty insurance platform underwriting targeted lines of business where pricing discipline, underwriting selectivity, and loss management matter more than broad retail distribution. The value chain is straightforward: the company assumes underwriting risk in exchange for premiums, manages that risk through underwriting standards and reinsurance programs, and earns additional returns from the investment of earned premium (“float”). Profitability is determined by the interaction of (i) underwriting performance (frequency/severity outcomes versus priced assumptions), (ii) reserve accuracy for incurred losses, and (iii) investment income and capital efficiency.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by earned insurance premiums, supported by investment income generated on accumulated reserves and policyholder cash flows. While premium streams renew based on underwriting performance and market conditions (not a contractual “monthly subscription”), the monetisation model is structurally recurring because policy portfolios are continually re-underwritten and expanded through renewal pricing and new writings. Margin drivers are underwriting-related (gross-to-net pricing strength, loss ratio outcomes, and expense leverage) and capital/investment-related (duration/credit quality of investments and the stability of capital held to support liabilities).

🧠 Competitive Advantages & Market Positioning

Core moat: underwriting and reserving “credit culture” plus regulatory/operational barriers. Specialty insurers can be difficult to replicate because sustained performance depends on disciplined risk selection, loss reserving competence, and durable relationships within the insurance and reinsurance ecosystem. These factors are largely intangible and cumulative—competitive advantage builds over time through track record, claims-handling capabilities, actuarial processes, and credibility with counterparties that fund and structure risk transfer.

  • Regulatory moat (license + capital framework): operating specialty insurance entities requires state/federal compliance, capital adequacy, and ongoing oversight. This raises entry friction and increases the likelihood that entrants face a learning curve (pricing, reserving, claims controls) that can take multiple underwriting cycles to overcome.
  • Credit culture & claims expertise (risk selection + reserving): specialty profitability hinges on avoiding mispriced risk and accurately reflecting incurred-but-not-reported losses. Competitors may have capital, but matching reserves discipline and underwriting judgement is the harder part.
  • Reinsurance market access (risk transfer credibility): structured reinsurance arrangements and terms are influenced by historical results and technical capabilities. Better risk-adjusted structures can improve net retention outcomes and volatility management.

Competitive benchmarking (specialty P&C):

  • Arch Capital Group: a highly diversified specialty insurer with broad underwriting reach across multiple sub-sectors.
  • Markel Group: strong underwriting depth and specialist lines, with a reputation for technical underwriting and claims management.
  • Argo Group: specialty focus across selected commercial insurance areas with an emphasis on underwriting control.

Compared with these peers, Bowhead’s positioning emphasizes the same underwriting fundamentals, but the practical differentiator is execution: disciplined pricing, structured risk transfer, and reserve accuracy in the company’s chosen niche segments—areas where underwriting judgement and operational controls tend to matter more than marketing scale.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, Bowhead’s opportunity set is shaped less by macro GDP growth and more by insurance market structure and risk complexity:

  • Ongoing demand for specialized underwriting as commercial risk becomes more complex (evolving liability exposures, contractual nuances, and concentrated or hard-to-model risks).
  • Continued “insurance adequacy” gaps in segments where insureds require tailored coverage and pricing accuracy; competitors with superior underwriting discipline can capture share through competence rather than breadth.
  • Underwriting cycle normalization in a market where discipline and capital management can translate into durable underwriting profitability and stronger reinvestment capacity.
  • Risk transfer sophistication: growth in reinsurance and alternative risk solutions supports platforms that can structure net exposures and manage volatility effectively.

⚠ Risk Factors to Monitor

  • Underwriting and reserve risk: adverse loss development, model risk, or inadequate reserving can pressure earnings and book value.
  • Catastrophe and severity correlation: even in “specialty” lines, large correlated events can distort loss expectations.
  • Reinsurance counterparty and pricing risk: reinsurance availability and terms can tighten, raising net exposure or costs.
  • Regulatory and capital constraints: capital requirements, reporting standards, and solvency oversight can limit growth or force balance-sheet conservatism.
  • Investment portfolio risk: duration, credit quality, and liquidity management affect investment income and the ability to withstand dislocation.

📊 Valuation & Market View

Specialty insurers are typically valued based on risk-adjusted profitability and balance-sheet quality rather than on operating multiple frameworks commonly used for non-financial businesses. Common investor focus areas include:

  • Book value durability and per-share compounding (reflecting underwriting and reserve outcomes).
  • Underwriting profitability metrics (loss and expense discipline, net retention efficiency, and volatility management).
  • Capital efficiency (how effectively the company converts equity capital into sustainable earnings).
  • Confidence in reserving and underwriting judgement (the market tends to reward credibility and penalize reserve deterioration).

Valuation improves when the market perceives stable underwriting performance, consistent loss reserve adequacy, and prudent capital deployment. Valuation risk rises when results suggest underwriting drift, reserve strengthening needs, or unfavorable risk transfer economics.

🔍 Investment Takeaway

Bowhead Specialty Holdings’ long-term investment case rests on an underwriting-driven model with a structural moat anchored in credit culture (risk selection and reserving discipline), operational/regulatory barriers, and reinsurance ecosystem credibility. The core question for investors is not growth alone, but whether the company can sustain risk-adjusted profitability through changing loss environments while maintaining balance-sheet strength and capital efficiency.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for BOW.

marketbeat.com2026-05-10

Bowhead Specialty Says AI Can Speed Underwriting Without Sacrificing Profit

Bowhead Specialty NYSE: BOW executives outlined how the specialty insurer is using technology, automation and artificial intelligence to improve underwriting workflows while maintaining a focus on underwriting profitability during a Deutsche Bank-hosted fireside chat.

seekingalpha.com2026-05-06

Bowhead Specialty Holdings Inc. (BOW) Discusses Technology and AI Advancements in Specialty Insurance Underwriting and Operations Transcript

Bowhead Specialty Holdings Inc. (BOW) Discusses Technology and AI Advancements in Specialty Insurance Underwriting and Operations Transcript

seekingalpha.com2026-05-05

Bowhead Specialty Holdings Inc. (BOW) Q1 2026 Earnings Call Transcript

Bowhead Specialty Holdings Inc. (BOW) Q1 2026 Earnings Call Transcript

zacks.com2026-05-05

Bowhead Specialty Holdings Inc. (BOW) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Bowhead Specialty Holdings Inc. (BOW) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com2026-05-05

Bowhead Specialty Holdings Inc. (BOW) Surpasses Q1 Earnings and Revenue Estimates

Bowhead Specialty Holdings Inc. (BOW) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.34 per share a year ago.

businesswire.com2026-05-05

Bowhead Specialty Holdings Inc. Reports First Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (NYSE: BOW), today announced financial results for the first quarter ended March 31, 2026.(1) First Quarter 2026 Highlights Gross written premiums increased 24.0% to $216.7 million. Net income of $16.0 million, or $0.48 per diluted share. Adjusted net income(2) of $16.0 million, or $0.48 per diluted share(2). Return on equity of 14.1% and adjusted return on equity(2) of 14.1%. Book value per share $13.98 and diluted book value per share.

zacks.com2026-04-28

Bowhead Specialty Holdings Inc. (BOW) Reports Next Week: Wall Street Expects Earnings Growth

Bowhead Specialty Holdings Inc. (BOW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

defenseworld.net2026-04-10

Bowhead Specialty (NYSE:BOW) and White Mountains Insurance Group (NYSE:WTM) Head to Head Review

Bowhead Specialty (NYSE: BOW - Get Free Report) and White Mountains Insurance Group (NYSE: WTM - Get Free Report) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership. Profitability This table compares Bowhead Specialty

businesswire.com2026-03-30

Bowhead Specialty to Announce First Quarter 2026 Earnings on May 5, 2026; Also Announces Upcoming Investor Events

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the “Company”, “Bowhead Specialty”) (NYSE: BOW) announced today that it will release financial results for the first quarter of 2026 at approximately 7:00 a.m. Eastern Time before the market opens on Tuesday, May 5, 2026. The earnings documents will be available on the Company's Investor Relations website at https://ir.bowheadspecialty.com. The Company will host a conference call to discuss its results on the same day, Tuesday, May 5,.

seekingalpha.com2026-02-24

Bowhead Specialty Holdings Inc. (BOW) Q4 2025 Earnings Call Transcript

Bowhead Specialty Holdings Inc. (BOW) Q4 2025 Earnings Call Transcript

zacks.com2026-02-24

Bowhead Specialty Holdings Inc. (BOW) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Bowhead Specialty Holdings Inc. (BOW) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com2026-02-24

Bowhead Specialty Holdings Inc. (BOW) Surpasses Q4 Earnings and Revenue Estimates

Bowhead Specialty Holdings Inc. (BOW) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.

businesswire.com2026-02-24

Bowhead Specialty Holdings Inc. Reports Fourth Quarter and Full Year 2025 Results

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (NYSE: BOW), a specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, delivered through complementary “craft” and “digital” underwriting models, today announced financial results for the fourth quarter and year ended December 31, 2025(1). Fourth Quarter 2025 Highlights Gross written premiums increased 21.3% to $224.1 million. Net income of $14.8 million, or $0.4.

businesswire.com2026-01-28

Bowhead Specialty to Announce Fourth Quarter 2025 Earnings on February 24, 2026; Also Announces Participation in Upcoming Investor Conferences

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (the “Company”, “Bowhead Specialty”) (NYSE: BOW) announced today that it will release financial results for the fourth quarter of 2025 at approximately 7:00 a.m. Eastern Time before the market opens on Tuesday, February 24, 2026. The earnings documents will be available on the Company's Investor Relations website at https://ir.bowheadspecialty.com. The Company will host a conference call to discuss its results on the same day, Tuesday,.

defenseworld.net2026-01-16

Bowhead Specialty Holdings Inc. (NYSE:BOW) Given Average Rating of “Moderate Buy” by Analysts

Shares of Bowhead Specialty Holdings Inc. (NYSE: BOW - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"BOW reported Q1 2026 revenue of $155.7M and net income of $16.0M (EPS $0.49). On a YoY basis, revenue rose +26.7% ($155.7M vs. $122.8M in Q1 2025) and net income increased +40.1% ($16.0M vs. $11.4M). QoQ, revenue improved +2.6% ($155.7M vs. $151.7M in Q4 2025) while net income edged up +7.9% ($16.0M vs. $14.8M). Profitability remained solid: the net margin improved to 10.3% from 9.8% in Q4 2025 and 9.3% in Q1 2025, indicating margin expansion over both horizons. Cash flow quality looks supportive. Operating cash flow was $65.5M and free cash flow was $64.2M in Q1 2026, with no dividends or buybacks reported. The balance sheet shows strong liquidity, with cash and short-term investments totaling $1.66B and zero reported total debt; total equity increased to $457.9M from $448.3M in Q4 2025. Total shareholder return is currently a headwind: the stock is down -38.1% over the last year (price $24.66) with no yield support (dividend yield reported as 0%). Analyst consensus targets (~$31.33) imply upside vs. the current price."

Revenue Growth

Good

YoY revenue growth of +26.7% in Q1 2026 (vs Q1 2025). QoQ revenue increased +2.6% vs Q4 2025, indicating a steady upward trajectory rather than a one-off quarter.

Profitability

Positive

Net margin expanded to 10.3% in Q1 2026 from 9.8% in Q4 2025 and 9.3% in Q1 2025. Net income rose +40.1% YoY and +7.9% QoQ alongside EPS increasing to $0.49.

Cash Flow Quality

Positive

Q1 2026 operating cash flow was $65.5M and free cash flow $64.2M, supporting earnings. No dividends were paid; no repurchases were reported, limiting shareholder return via cash distribution.

Leverage & Balance Sheet

Strong

Zero reported debt with high liquidity: cash + short-term investments of $1.66B in Q1 2026. Total equity improved to $457.9M from $448.3M QoQ, suggesting resilience.

Shareholder Returns

Neutral

Price performance is negative: -38.1% over the last year and -10.1% YTD, with dividend yield at 0%. No buybacks reported, so total return is currently weak.

Analyst Sentiment & Valuation

Neutral

Consensus price target ($31.33) vs. current price ($24.66) implies potential upside, but the stock’s recent momentum is strongly negative, tempering the valuation/expectations outlook.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Bowhead started 2026 with broad top-line momentum and improved profitability, driven by disciplined premium growth and better expense efficiency. Q1 GWP rose 24% to ~$217M and adjusted net income increased ~40% to $16M, with adjusted EPS of $0.48. The combined ratio was 95.3% as the loss ratio held at 66.9% while the expense ratio fell 2 points YoY to 28.4%, largely from a lower operating expense ratio partly offset by higher net acquisition ratios. The digital engines are emerging as a structural lever: Baleen produced $11.4M premium with >75% of submissions responding within 15 minutes, while Express generated over $3M premium and is positioned for additional product expansion, including a primary casualty launch expected later in the month. Reinsurance also shifted risk economics—quota share up to 33.5% and excess of loss down to 57.5%—with management stating bottom-line impact is roughly neutral to net income. Key headwinds remain pricing pressure in casualty and uncertainty in healthcare sexual abuse/molestation coverage, but management views underwriting discipline and reinsurance/capital actions as mitigating factors.

AI IconGrowth Catalysts

  • Casualty growth driven by excess portfolio, including strong rate on real estate book, new construction projects, and increased manufacturing and hospitality business
  • Professional liability growth driven by Cyber liability Bowhead Express portfolio targeting small and midsized accounts through digital underwriting
  • Healthcare Liability GWP up 28% driven by hospitals, senior care, and miscellaneous medical facilities portfolios despite challenging sexual abuse and molestation coverage conditions
  • Baleen delivered over $11 million premium in the quarter; new business submissions up over 140% and new business quotes up over 110%
  • Express grew over $3 million premium in the quarter with a quote ratio around 65%, with a roadmap toward primary casualty for middle market construction risks later in 2026

Business Development

  • Expanded agreement with American Family to support expected ~20% GWP growth; increased $1 billion annual premium cap (projected to be exceeded in 2026)
  • Reinsurance renewals effective May 1: increased quota share from 26% (2025) to 33.5% and increased ceding commissions; decreased excess of loss from 65% to 57.5%, placed with reinsurers rated A or better by AM Best
  • Wholesale broker expansion and digitally native programmatic platforms targeted by Baleen; emphasis on bid/quote speed and bindable quotes driving repeat broker engagement

AI IconFinancial Highlights

  • Gross written premiums increased 24% YoY to ~$217 million
  • Adjusted net income $16 million, up ~40% YoY
  • Diluted adjusted EPS $0.48 for the quarter
  • Loss ratio 66.9%, unchanged YoY; current accident year loss ratio flat due to loss pick impact in Q4 2025 offset by business mix changes
  • Expense ratio 28.4%, down 2.0 points YoY (from 30.4%); operating expense ratio decreased 2.9 points while net acquisition ratio increased 1.2 points
  • Combined ratio 95.3% for the quarter
  • Pre-tax net investment income up ~44% YoY to $18 million; book yield 4.6%, new money rate 4.7%; investment average credit quality AA-; duration increased 3.0 years end 2025 to 3.2 years end of quarter
  • Effective tax rate 22.2%; may vary with state taxes, stock-based comp, nondeductible excess officer comp
  • Q1 digital mix: digital underwriting just under 7% of total Bowhead GWP

AI IconCapital Funding

  • Debt: $150 million debt raise completed in late 2025; CFO indicated it should last through 2026 (at least through this year)
  • Liquidity: $35 million credit facility with $15 million accordion
  • Capital management: no buyback or new capital management actions mentioned beyond reinsurance update and prior debt raise

AI IconStrategy & Ops

  • Baleen automation performance: >75% of new submissions received response within 15 minutes; 100% within 1 business day; new business quote ratio above 75%; complete policy delivery in under 5 minutes upon purchase
  • Baleen underwriting model: codified business rules for eligibility/pricing/coverage with third-party data validation at submission; underwriter judgment constrained to decision points; performance monitoring via actuarial/analytics
  • Express operating model: underwriter review structured to take <15 minutes per risk; aggregate internal and third-party data upfront; minimal broker back-and-forth; goal of no-touch capabilities for smallest risks
  • Expense timing item: Q1 updated estimate of deferrable internal acquisition-related costs; CFO characterized as favorable timing item expected to normalize in future quarters
  • May 1 reinsurance renewals adjusted capital structure: increased quota share and decreased excess of loss

AI IconMarket Outlook

  • Digital contribution outlook: expect Baleen and Express contribution to grow through the year; specifically expects digital underwriting to increase from just under 7% of total GWP in Q1
  • Express product roadmap: later this month expected launch of primary casualty offering for middle market construction risks
  • Baleen growth roadmap: broker expansion and product development; both designed to expand addressable market without compromising limits/coverage
  • Expense ratio guidance (operational comfort): CFO indicated they are comfortable below 30% total and suggested that if below 30s in remaining 2026 quarters that is “pretty good”
  • Capital runway: management expects debt raise and reinsurance changes to keep the company set on capital for 2026 absent growth materially above expectations

AI IconRisks & Headwinds

  • Casualty downward pricing pressure from an overabundance of supply; admitted carriers, nonrisk-bearing MGAs, and broker sidecars noted as potential pressure (with exceptions)
  • Healthcare liability market challenging due to sexual abuse and molestation coverage; marketplace bifurcation tied to reviver statutes and attachment/retention conditions
  • Cyber tail-risk concerns from evolving AI technologies (analyst asked); management argued underwriting approach reduces exposure and that they are less competitive in Fortune 500 cyber while focusing on SMB segments
  • Expense ratio volatility risk: management cautioned not to over-interpret one quarter, though Q1 had a favorable timing item in deferrable costs
  • Reserve process risk: very high IBNR as % of total reserves (91% at quarter end); company relies on industry observed loss data due to long-tail lines and shorter loss history

Q&A: Analyst Interest

  • Buying-rate drivers for Baleen: Management attributed higher bind/quote response performance to increased time in market, stronger broker familiarity and distribution investment, and greater visibility/top-of-mind status with wholesale partners. They emphasized improved experience and relevance rather than underwriting rule changes alone.
  • Expense ratio normalization and deferrable costs: Management clarified the Q1 underwriting/expense change includes an updated estimate of deferrable internal costs tied to acquisitions, described as a favorable timing item. These costs amortize into acquisition costs and are expected to normalize across future quarters.
  • Healthcare Liability underwriting cycle and cyber tail-risk: Management described healthcare as a flux market with sexual abuse/molestation claim dynamics influenced by reviver statutes, bifurcating based on attachment points/retentions and insurer behavior. For cyber, they emphasized segment selection and underwriting screens (e.g., multifactor authentication) to mitigate tail-risk and AI-driven threats.

Sentiment: MIXED

Note: This summary was synthesized by AI from the BOW Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for BOW.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (BOW)

© 2026 Stock Market Info — Bowhead Specialty Holdings Inc. (BOW) Financial Profile